Celebrating 20 Years of IP Excellence

Image accompanying blogpost on "Cancerous Battle: Novartis and NATCO clash over Eltrombopag"

Cancerous Battle: Novartis and NATCO clash over Eltrombopag

In a landmark decision, the Delhi High Court overturned an injunction against Natco, allowing them to produce a generic version of Novartis’s cancer drug. The Court held that Novartis’s patent on a specific salt form of the drug (ELT-O) lacked novelty due to its coverage in an earlier patent (IN’176). Continue Reading Cancerous Battle: Novartis and NATCO clash over Eltrombopag

Read more

The featured image shows the picture of the generic drug Temazepam. This post is about the new EU trademark law that is causing concern for India. To read more click here.

EU Trademark law threatens Indian Generic Export Market

  The European Parliament and The Council of The European Union recently passed the Regulation (EU) 2015/2424 . The legislation concerns an amendment to the European Union trademark law. The new legislation has India worried as it enlists stringent enforcement provisions that allow customs officials to seize foreign consignments en route to third countries if they contain items with brand names or logos similar to those registered as trademarks in the 28-member nations of the EU block. The specific provisions that…

Read more

Connect with Us

BananaIP Counsels

No.40, 3rd Main Road, JC Industrial Estate, Kanakapura Road, Bangalore – 560 062.

Telephone: +91-76250 93758+91-80-49536207 | +91-80-26860414/24/34
Email: contact@bananaip.com

Please enable JavaScript in your browser to complete this form.
Checkboxes

© 2004-2024 BananaIP Counsels. All Rights Reserved.